Type 1 Diabetes - Medika Life

Cardiovascular disease is the number one cause of death among high-income countries and is projected to be the leading cause of death worldwide by 2030.

Exponential Innovation: Disrupting The Disruptor

John Nosta - January 5, 2022

Today's world of disruptive change is defined by two terms: innovation and speed. The big idea is important, but equally so is the path that innovation...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

The Diabetes Epidemic: A Pressing Public Health Catastrophe

New York Tackles Insulin Access Hurdles as Governor Hochul Takes on Therapy Costs

Will Blood Glucose Become The New Blood Pressure?

LATEST

TRENDING

Exponential Innovation: Disrupting The Disruptor

New York Tackles Insulin Access Hurdles as Governor Hochul Takes on Therapy Costs

CDC Lost Round One – But the Public Health Match Continues

Taking On Prediabetes Could be America’s Best Defense Against COVID-19

Hypoglycemia, Low Blood Glucose

Hesitant to Discuss Weight with Your Patients?

Coffee Lower Diabetes Risk, But There’s a Catch

Type 1 Diabetes, Risks and Treatment

One Trick to Lowering Heart Risk: Friends Have Benefits

Takeaway and Delivery Meals Make You Fat, Start Cooking Your Own Food

EDITORS CHOICE

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Taking On Prediabetes Could be America’s Best Defense Against COVID-19

One Trick to Lowering Heart Risk: Friends Have Benefits

Exponential Innovation: Disrupting The Disruptor

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories